The Effect of Canagliflozin on Hippocampal Dendrite Morphology in a Model of Alzheimer's Disease Induced by Intracerebroventricular Injection of Streptozotocin
Year: 2023
Type: article
Abstract: Introduction: Streptozotocin is used for experimental Alzheimer's disease model. Canagliflozin (an anticholinesterase and SGLT inhibitor), a new oral antidiabetic, has an effect on cognitive damage and biochemical parameters in the Alzheimer's disease model. The aim of the study is to examine the effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer's disease induced by intracerebroventricular injection of streptozotocin.
Source: IBRO Neuroscience Reports
Institution: Marmara University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,500
Award: G7073872701
OpenAlex ID: W4388364217
